Mr. Rajat Gupta Asked for $6.2 Million as Compensation

Mr. Rajat Gupta Asked for $6.2 Million as Compensation

After the accusations against the Goldman Sachs director, Rajat K. Gupta, for breaching loyalty after he was found leaking information of boardrooms to the hedge fund manager Raj Rajaratnam, he has been convicted over the charges.

He has been charged with the breach of loyalty and has been asked to reimburse more than $6.2 million. This is the amount that the bank had to give to the counsel at the law firm Sullivan & Cromwell for an internal investigation and other legal expenses.

The bank has asked for the money on the basis of the Mandatory Victims Restitution Act. The law allows the victims to receive the compensation for losses because of the insider trading crime by the disloyal employee.

The charges were verified when the judge Rakoff did not find any evidence that spoke in defense of the accused. After checking 542 pages of company's billing records, it was seen that there was a cut in the bill by 10% after there were some outside entries.

A federal judge announced his judgment and asked for two years of imprisonment for him. He is out on bail but has been asked for restitution.

According to Michael Duvally, a Goldman spokesman said that the bank was happy with the fact that Mr. Gupta was asked to pay for the compensation.

Business: 
People: 
General: 
Companies: 

Popular Stories

Flu vaccine is 48% effective this season: CDC

Flu vaccine has reduced the risk of infections in... Read More

Erosion of beaches will get worse: researchers warn

Portraying a gloomy picture of the future, the 2015... Read More

Rare rat-linked disease leaves 1 dead, 2 sickened in Bronx

A rare bacterial disease carried by rats has killed... Read More

Try drug-free remedies before resorting to medication for low back pain: ACP

People suffering low back pain should try drug-free... Read More

Pregnant inmate forced to deliver baby on jail cell floor

A Detroit-area sheriff has defended his staff over... Read More

Marathon Pharma to sell decades-old drug to treat DMD for $89,000

Marathon Pharmaceuticals will reportedly market... Read More